Clinical Trial Update: National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

View source ↗

Summary

The PROS clinical trial (NCT05563831) has completed, providing an update on patients with PIK3CA-related overgrowth spectrum and related conditions such as CLOV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cloves Syndrome
• Klippel-trénaunay Syndrome
• Lymphatic Malformation
• Macrodactyly
• Megalencephaly-capillary Malformation Syndrome
• Pik3ca-related Overgrowth Spectrum
• Vascular Malformations
• Venous Malformation

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: PIK3CA-related Overgrowth Spectrum, CLOVES Syndrome | Status: COMPLETED